Found 10 matching trials
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma PHASE1 RATIONALE: Vaccines made from peptides may help the body build an effective...
Show More Location
Fox Chase Cancer Center - Philadelphia
Learn More & Join Trial
Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma PHASE2 This clinical pilot study will test the hypothesis that systemic low-dose I...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma PHASE1 The goals of this study are to evaluate 1) the safety of administration of ...
Show More Location
University of Virginia
Learn More & Join Trial
Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma PHASE1 RATIONALE: Vaccines made from peptides may help the body build an effective...
Show More Location
University of Virginia Cancer Center
Learn More & Join Trial
Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma PHASE2 This is an open-label, phase II study of a vaccine comprising melanoma pept...
Show More Location
University of Virginia
Learn More & Join Trial
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines made from peptides may make the body build an immune re...
Show More Location
Veterans Affairs Medical Center - Palo Alto
Learn More & Join Trial
Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists PHASE1 The purpose of this study is to learn what effects (good and bad) an experi...
Show More Location
MDAnderson Cancer Center
Learn More & Join Trial
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma PHASE2 RATIONALE: Vaccines made from melanoma cells may make the body build an imm...
Show More Location
Cancer Center at the University of Virginia
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Advanced Melanoma PHASE1 RATIONALE: Vaccine therapy may help the body build an effective immune resp...
Show More Location
University of Virginia Cancer Center
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Vaccines made from peptide 946 may make the body build an immune...
Show More Location
Cancer Center, University of Virginia HSC
Learn More & Join Trial